BISPHOSPHONATES, intravenous for treating osteoporosis - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

BISPHOSPHONATES, intravenous for treating osteoporosis

Last Updated: 27 September 2019

Body System: Endocrine System

Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of INTRAVENOUS BISPHOSPHONATES (ibandronic acid and zoledronic acid), by specialists only, for treating osteoporosis in accordance with NICE TA464.